NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

Once DCVax-L TLD is released, they will need all the shares to meet demand. Anyone who has traded for more than a year, knows institutional interest, demands millions of extra shares to fulfill their own need for positions. Therefore, the extra shares will be absorbed quickly by those entities wishing to be invested in a new SOC for many cancers, but most certainly Glioblastoma.